Boxer Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,726,000
| Closed | -$49.8M | – | 4 |
|
|
2024
Q3 | $49.8M | Hold |
1,726,000
| – | – | 2.44% | 13 |
|
|
2024
Q2 | $66.2M | Hold |
1,726,000
| – | – | 3.49% | 12 |
|
|
2024
Q1 | $101M | Hold |
1,726,000
| – | – | 5.01% | 5 |
|
|
2023
Q4 | $103M | Hold |
1,726,000
| – | – | 5.15% | 5 |
|
|
2023
Q3 | $65.7M | Buy |
1,726,000
+150,000
| +10% | +$5.71M | 3.5% | 9 |
|
|
2023
Q2 | $144M | Hold |
1,576,000
| – | – | 6.66% | 2 |
|
|
2023
Q1 | $104M | Hold |
1,576,000
| – | – | 5.11% | 5 |
|
|
2022
Q4 | $81.5M | Buy |
1,576,000
+272,300
| +21% | +$14.1M | 4.3% | 7 |
|
|
2022
Q3 | $89M | Hold |
1,303,700
| – | – | 5.01% | 5 |
|
|
2022
Q2 | $59M | Hold |
1,303,700
| – | – | 3.73% | 5 |
|
|
2022
Q1 | $66.2M | Buy |
+1,303,700
| New | +$66.2M | 3.4% | 10 |
|
|
2020
Q1 | – | Sell |
-800,000
| Closed | -$24.5M | – | 62 |
|
|
2019
Q4 | $24.5M | Buy |
800,000
+100,000
| +14% | +$3.06M | 1.39% | 20 |
|
|
2019
Q3 | $16.9M | Buy |
+700,000
| New | +$16.9M | 1.22% | 24 |
|